158 related articles for article (PubMed ID: 38506898)
61. Verification of Ferroptosis Subcluster-Associated Genes Related to Osteosarcoma and Exploration of Immune Targeted Therapy.
Jiang M; Jike Y; Gan F; Li J; Hu Y; Xie M; Liu K; Qin W; Bo Z
Oxid Med Cell Longev; 2022; 2022():9942014. PubMed ID: 36211822
[TBL] [Abstract][Full Text] [Related]
62. A novel molecular signature for predicting prognosis and immunotherapy response in osteosarcoma based on tumor-infiltrating cell marker genes.
Tang H; Liu S; Luo X; Sun Y; Li X; Luo K; Liao S; Li F; Liang J; Zhan X; Wei Q; Liu Y; He M
Front Immunol; 2023; 14():1150588. PubMed ID: 37090691
[TBL] [Abstract][Full Text] [Related]
63. New gene signature from the dominant infiltration immune cell type in osteosarcoma predicts overall survival.
Gong L; Sun X; Jia M
Sci Rep; 2023 Oct; 13(1):18271. PubMed ID: 37880378
[TBL] [Abstract][Full Text] [Related]
64. Ferroptosis-related lncRNAs guiding osteosarcoma prognosis and immune microenvironment.
Yang M; Su Y; Xu K; Zheng H; Yuan Q; Cai Y; Aihaiti Y; Xu P
J Orthop Surg Res; 2023 Oct; 18(1):787. PubMed ID: 37858131
[TBL] [Abstract][Full Text] [Related]
65. Integrative analyses of ferroptosis and immune related biomarkers and the osteosarcoma associated mechanisms.
Li G; Lei J; Xu D; Yu W; Bai J; Wu G
Sci Rep; 2023 Apr; 13(1):5770. PubMed ID: 37031292
[TBL] [Abstract][Full Text] [Related]
66. Dissecting the effect of sphingolipid metabolism gene in progression and microenvironment of osteosarcoma to develop a prognostic signature.
Zhong Y; Zhang Y; Wei S; Chen J; Zhong C; Cai W; Jin W; Peng H
Front Endocrinol (Lausanne); 2022; 13():1030655. PubMed ID: 36313783
[TBL] [Abstract][Full Text] [Related]
67. Development of an immune-related signature for predicting survival outcome and immunotherapy response in osteosarcoma.
Wang Q; Zhang W; Guo Y; Li Y; Fu K
Aging (Albany NY); 2021 Nov; 13(21):24155-24170. PubMed ID: 34747719
[TBL] [Abstract][Full Text] [Related]
68. Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer.
Zhang Z; Wang J; Han W; Zhao L
BMC Gastroenterol; 2023 Apr; 23(1):132. PubMed ID: 37081402
[TBL] [Abstract][Full Text] [Related]
69. Identification and Validation of a Potent Multi-miRNA Signature for Prediction of Prognosis of Osteosarcoma Patients.
Luo X; Tang J; Xuan H; Liu J; Li X
Med Sci Monit; 2020 Feb; 26():e919272. PubMed ID: 32098942
[TBL] [Abstract][Full Text] [Related]
70. Identification of 6 gene markers for survival prediction in osteosarcoma cases based on multi-omics analysis.
Li R; Wang G; Wu Z; Lu H; Li G; Sun Q; Cai M
Exp Biol Med (Maywood); 2021 Jul; 246(13):1512-1523. PubMed ID: 33563042
[TBL] [Abstract][Full Text] [Related]
71. Development of a Machine Learning-Based Autophagy-Related lncRNA Signature to Improve Prognosis Prediction in Osteosarcoma Patients.
Zhang GZ; Wu ZL; Li CY; Ren EH; Yuan WH; Deng YJ; Xie QQ
Front Mol Biosci; 2021; 8():615084. PubMed ID: 34095215
[TBL] [Abstract][Full Text] [Related]
72. Osteosarcoma-Associated Immune Genes as Potential Immunotherapy and Prognosis Biomarkers.
Yang L; Long Y; Xiao S
Biochem Genet; 2024 Apr; 62(2):798-813. PubMed ID: 37452172
[TBL] [Abstract][Full Text] [Related]
73. The immune cell infiltration-associated molecular subtypes and gene signature predict prognosis for osteosarcoma patients.
Liu B; Liu XY; Wang GP; Chen YX
Sci Rep; 2024 Mar; 14(1):5184. PubMed ID: 38431660
[TBL] [Abstract][Full Text] [Related]
74. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
[No Abstract] [Full Text] [Related]
75. Immunogenic profiling of metastatic uveal melanoma discerns a potential signature related to prognosis.
Wang J; Liu M; Sun J; Zhang Z
J Cancer Res Clin Oncol; 2024 Jan; 150(1):23. PubMed ID: 38246894
[TBL] [Abstract][Full Text] [Related]
76. Construction and validation of an oxidative-stress-related risk model for predicting the prognosis of osteosarcoma.
Wang H; Li J; Li X
Aging (Albany NY); 2023 Jun; 15(11):4820-4843. PubMed ID: 37285835
[TBL] [Abstract][Full Text] [Related]
77. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
[TBL] [Abstract][Full Text] [Related]
78. Immunogenic cell death related mRNAs associated signature to predict immunotherapeutic response in osteosarcoma.
Han S; Wang Q; Shen M; Zhang X; Wang J
Heliyon; 2024 Mar; 10(6):e27630. PubMed ID: 38515694
[TBL] [Abstract][Full Text] [Related]
79. Exploration of Immune-Related Gene Expression in Osteosarcoma and Association With Outcomes.
Liu W; Xie X; Qi Y; Wu J
JAMA Netw Open; 2021 Aug; 4(8):e2119132. PubMed ID: 34342651
[TBL] [Abstract][Full Text] [Related]
80. Prognostic Signature of Osteosarcoma Based on 14 Autophagy-Related Genes.
Qi W; Yan Q; Lv M; Song D; Wang X; Tian K
Pathol Oncol Res; 2021; 27():1609782. PubMed ID: 34335109
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
